These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5765461)

  • 21. Derivatives of the complement component MuB1 (C5mu) and separation of a factor involved in the conversion of MuB1 to MuB1f.
    Naylor DH; Cinader B
    Int Arch Allergy Appl Immunol; 1970; 39(5-6):540-65. PubMed ID: 4250087
    [No Abstract]   [Full Text] [Related]  

  • 22. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli.
    Schiffmann E; Showell HV; Corcoran BA; Ward PA; Smith E; Becker EL
    J Immunol; 1975 Jun; 114(6):1831-7. PubMed ID: 165239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor.
    Ward PA; Remold HG; David JR
    Cell Immunol; 1970 Jul; 1(2):162-74. PubMed ID: 4108781
    [No Abstract]   [Full Text] [Related]  

  • 24. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    NILSSON UR; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):277-98. PubMed ID: 14316946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 26. Tick-bite injury: mediation by a complement-derived chemotictic chemotactic factor.
    Berenberg JL; Ward PA; Sonenshine DE
    J Immunol; 1972 Sep; 109(3):451-6. PubMed ID: 5055180
    [No Abstract]   [Full Text] [Related]  

  • 27. On the cleavage of C'2 by C'la: immunological and physical comparisons of C'2ad and C'2a-i.
    Miller JA; Mayer MM
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):127-30. PubMed ID: 5686497
    [No Abstract]   [Full Text] [Related]  

  • 28. Complement components of a haemolytically deficient strain of rabbits.
    Nelson RA; Biro CE
    Immunology; 1968 Apr; 14(4):527-40. PubMed ID: 5653813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gammaG-mediated in vitro phagocytosis by the Clq component of complement.
    Messner RP; Jelinek JG
    Clin Immunol Immunopathol; 1973 Jan; 1(2):203-11. PubMed ID: 4797033
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation and characterization of an acidic chemotactic factor from complement-activated human serum.
    Beebe DP; Ward PA; Spitznagel JK
    Clin Immunol Immunopathol; 1980 Jan; 15(1):88-105. PubMed ID: 7357760
    [No Abstract]   [Full Text] [Related]  

  • 31. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    Cochrane CG; Müller-Eberhard HJ; Aikin BS
    J Immunol; 1970 Jul; 105(1):55-69. PubMed ID: 4246566
    [No Abstract]   [Full Text] [Related]  

  • 32. The ontogenetic development of the later complement components in fetal piglets.
    Geiger H; Day N; Good RA
    J Immunol; 1972 Apr; 108(4):1098-104. PubMed ID: 5063310
    [No Abstract]   [Full Text] [Related]  

  • 33. The separation of nine components and two inactivators of components of complement in humansserum.
    Vroon DH; Schultz DR; Zarco RM
    Immunochemistry; 1970 Jan; 7(1):43-61. PubMed ID: 5416393
    [No Abstract]   [Full Text] [Related]  

  • 34. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex.
    Kolb WP; Muller-Eberhard HJ
    J Exp Med; 1975 Apr; 141(4):724-35. PubMed ID: 47885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabbit polymorphonuclear leukocyte chemotactic factor generated in vivo by Bacteroides fragilis lipopolysaccharide. I. Isolation and physico-chemical characterization.
    Sveen K
    Acta Pathol Microbiol Scand B; 1978 Aug; 86(4):229-36. PubMed ID: 358747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.
    Altman LC; Snyderman R; Oppenheim JJ; Mergenhagen SE
    J Immunol; 1973 Mar; 110(3):801-10. PubMed ID: 4688920
    [No Abstract]   [Full Text] [Related]  

  • 37. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 38. Clevage of human Clś by human lysosomal enzymes, plasmin, and trypsin.
    Taubman SB; Lepow IH
    Immunochemistry; 1971 Oct; 8(10):951-61. PubMed ID: 4261121
    [No Abstract]   [Full Text] [Related]  

  • 39. Biologic role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis.
    Ward PA; Hill JH
    J Immunol; 1972 May; 108(5):1137-45. PubMed ID: 4260453
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro and in vivo production of chemotactic inhibitors by tumor cells.
    Cohen MC; Brozna JP; Ward PA
    Am J Pathol; 1979 Mar; 94(3):603-14. PubMed ID: 106732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.